Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

The closing of the Offering is expected to occur on or about February 7, 2025, subject to the satisfaction of customary ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Given the success of the previous Research Topic 'Exploring Small Molecule Inhibitors in Cardiovascular and Cerebrovascular Diseases', we are pleased to ...

pathogenic mechanisms and therapeutic targets. Researchers have identified autoinflammatory pathways linked to mitochondrial dysfunction or overactivation of SRC family kinases. For individuals ...

The exploration of natural products and their structural analogues in neuropsychiatry has historically been a fertile area of research, driven by the ...

Thousands of treated patients support the potential of phage therapy, but limited knowledge of this technique and its regulatory complexity hinder its expansion ...

Innovative targeted oncology company built on next-generation ADCs and a novel discovery engine Connect with the Company on ...

Digital therapeutics can also be used to manage ... end-to-end discovery lab dedicated to inventing and validating novel mechanisms of action. During our research and development process, we ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds momentum with both Fast Track and Orphan Drug Designations.

They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...